Recent Quotes
View Full List
My Watchlist
01 Quantum Inc
DEFSEC Technologies Inc. - common stock, no R/S concurrent with offering
Defiance Leveraged Long + Income MSTR ETF
Exascale Labs Holdings Inc. - Class A Common Stock
INNIO N.V. - Ordinary Shares
Integra LifeSciences Holdings Corporation - Common Stock
Invesco S&P MidCap Quality ETF
Itm Power Plc
Iunits S&P/Tsx Capped Energy Index Fund
Lifeward Ltd. - Ordinary Shares
Maui Land & Pineapple Company, Inc. Common Stock
Medical Care Technologies Inc
Mercari Inc
MicroVision, Inc. - Common Stock
Mitsui O.S.K. Lines ADR
Nxt Energy Solutions Inc
Paladin Energy Ltd
Peer To Peer Network
Pirate Gold Corp
Principal Contrarian Value Index ETF
Scorpius Holdings, Inc. Common Stock
Silicon Laboratories, Inc. - Common Stock
Solstice Advanced Materials Inc. - Common Stock
Spectaire Holdings, Inc. - Warrants
Strikepoint Gold Inc
Sunshine Biopharma Inc. - Common stock
Traction Uranium Corp
Trinity Biotech plc - American Depositary Shares
VanEck Industrials TruSector ETF
Vecima Networks Inc
Vencanna Ventures Inc.
ViacomCBS Inc. - Class A Common Stock
Yorkville Acquisition Corp. - Class A Ordinary Share
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ArriVent BioPharma, Inc. - Common Stock
(NQ:
AVBP
)
16.66
-0.13 (-0.77%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about ArriVent BioPharma, Inc. - Common Stock
AVBP Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into ArriVent BioPharma (AVBP)
October 08, 2026
From
Levi & Korsinsky, LLP
Via
ACCESS Newswire
AVBP Investors with $100,000 in Losses Have Opportunity to Join ArriVent BioPharma, Inc. Fraud Investigation with SBS Law
October 07, 2026
From
Schall, Brown & Schwartz LLP
Via
Business Wire
ArriVent BioPharma Reports First Quarter 2024 Financial Results
May 08, 2024
From
ArriVent BioPharma, Inc.
Via
GlobeNewswire
ArriVent Appoints Kristine Peterson to its Board of Directors
April 22, 2024
From
ArriVent BioPharma, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.